Can AI Tell you if You Have Osteoporosis?

Osteoporosis is so difficult to detect in early stage it’s called the "silent disease." What if artificial intelligence could help predict a patient’s chances of having the bone-loss disease before ever stepping into a doctor's office?

Tulane University researchers made progress toward that vision by developing a new deep learning algorithm that outperformed existing computer-based osteoporosis risk prediction methods, potentially leading to earlier diagnoses and better outcomes for patients with osteoporosis risk.

Their results were recently published in Frontiers in Artificial Intelligence.

Deep learning models have gained notice for their ability to mimic human neural networks and find trends within large datasets without being specifically programmed to do so. Researchers tested the deep neural network (DNN) model against four conventional machine learning algorithms and a traditional regression model, using data from over 8,000 participants aged 40 and older in the Louisiana Osteoporosis Study. The DNN achieved the best overall predictive performance, measured by scoring each model’s ability to identify true positives and avoid mistakes.

"The earlier osteoporosis risk is detected, the more time a patient has for preventative measures," said lead author Chuan Qiu, a research assistant professor at the Tulane School of Medicine Center for Biomedical Informatics and Genomics. "We were pleased to see our DNN model outperform other models in accurately predicting the risk of osteoporosis in an aging population."

In testing the algorithms using a large sample size of real-world health data, the researchers were also able to identify the 10 most important factors for predicting osteoporosis risk: weight, age, gender, grip strength, height, beer drinking, diastolic pressure, alcohol drinking, years of smoking, and income level.

Notably, the simplified DNN model using these top 10 risk factors performed nearly as well as the full model which included all risk factors.

While Qiu admitted that there is much more work to be done before an AI platform can be used by the public to predict an individual’s risk of osteoporosis, he said identifying the benefits of the deep learning model was a step in that direction.

"Our final aim is to allow people to enter their information and receive highly accurate osteoporosis risk scores to empower them to seek treatment to strengthen their bones and reduce any further damage," Qiu said.

Qiu C, Su K, Luo Z, Tian Q, Zhao L, Wu L, Deng H, Shen H.
Developing and comparing deep learning and machine learning algorithms for osteoporosis risk prediction.
Front Artif Intell. 2024 Jun 11;7:1355287. doi: 10.3389/frai.2024.1355287

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...